FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
Project Oncology® - Un pódcast de ReachMD
Categorías:
FDA medical oncologists discuss the agency’s March 23, 2017 approval of avelumab for the treatment of patients 12 years and older with metastatic Merkel cell carcinoma. Released May 22, 2017
